<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01440673</url>
  </required_header>
  <id_info>
    <org_study_id>GIRBA2085</org_study_id>
    <nct_id>NCT01440673</nct_id>
  </id_info>
  <brief_title>Aprepitant for Postoperative Nausea and Vomiting in Laparoscopic Hysterectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gachon University Gil Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gachon University Gil Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Gynecological surgery is associated with a high incidence of postoperative nausea and&#xD;
           vomiting.&#xD;
&#xD;
        -  NK1 receptor antagonists such as aprepitant appear to be highly effective for treating&#xD;
           acute and delayed emesis, and yet understanding of the efficacy of different doses of&#xD;
           aprepitant is limited.&#xD;
&#xD;
        -  We performed a prospective, randomized, double-blinded placebo-controlled study of 123&#xD;
           female adults scheduled for laparoscopic hysterectomy who received 80 mg aprepitant, 125&#xD;
           mg aprepitant, or a placebo.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      123 female patients (ages 21-60) undergoing laparoscopic hysterectomy&#xD;
&#xD;
        1. 80mg aprepitant&#xD;
&#xD;
        2. 125mg aprepitant&#xD;
&#xD;
        3. placebo&#xD;
&#xD;
      Incidences of nausea, vomiting/retching, and use of rescue antiemetics were recorded at 0, 1,&#xD;
      2, 24, and 48 h after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The numbers (and percentages) of patients who experienced complete response</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>The numbers (and percentages) of patients who experienced complete response, i.e. no nausea, retching, vomiting, or need for rescue treatment&#xD;
required rescue therapy and peak nausea scores&#xD;
Adverse effects in the three treatment groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>aprepitant 125mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NK1 receptor antagonist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aprepitant 80 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aprepitant</intervention_name>
    <description>Aprepitant 80 mg, Aprepitant 125 mg</description>
    <arm_group_label>Aprepitant 80 mg</arm_group_label>
    <arm_group_label>aprepitant 125mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  female laparoscopic hysterectomy isoflurane anesthesia postoperative opioid use&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  liver disease neurologic disease active pulmonary disease cardiac arrhythmia allergies&#xD;
             to any perioperative medications&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>WOL SEON JUNG, M.D. Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gil Medical Center Gachon University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gil Medical Center Gachon University</name>
      <address>
        <city>Inchon</city>
        <zip>405-760</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <study_first_submitted>September 20, 2011</study_first_submitted>
  <study_first_submitted_qc>September 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2011</study_first_posted>
  <last_update_submitted>September 23, 2011</last_update_submitted>
  <last_update_submitted_qc>September 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gachon University Gil Medical Center</investigator_affiliation>
    <investigator_full_name>Wol Seon Jung</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Postoperative Nausea and Vomiting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aprepitant</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

